8.7
Excellent
376 reviews
- Communication
- 8.8
- Timeliness
- 8.9
- Accuracy
- 7.6
- Staff
- 8.8
- Value
- 8.9
Krista Kutch
8.9
- - Stability Studies
- - 18 months January 2023 - June 2024
- - Pharmaceutical Company
Reviewed:
Accurate and reliable stability studies, clear reporting.
The stability studies were conducted with precision, and the reporting was clear and thorough. The results provided us with the necessary data to proceed with our regulatory submissions confidently.
Edna Dibbert
8.9
- - Regulatory Submission
- - 6 weeks February 2023
- - Biotech Startup
Reviewed:
Professional and knowledgeable, seamless regulatory submission process.
Our regulatory submission was handled with great care and expertise. The process was seamless, and their knowledge of the regulatory landscape was impressive. The team's support was invaluable, and I would not hesitate to use their services again.
Keith Schimmel PhD
5.6
- - Clinical Data Management
- - 8 weeks December 2023 - February 2024
- - Biotech Company
Reviewed:
Delayed delivery and lack of communication during the project.
The data management services were delayed, and communication from the team was lacking. It was difficult to get updates, and when the deliverables arrived, they were not as polished as expected. The delays impacted our project timeline significantly.
Brittany Brown
9.1
- - Clinical Data Management
- - 6 weeks June - July 2023
- - CRO
Reviewed:
Timely and accurate data management, great collaboration.
The data management services were delivered on time and with great accuracy. Collaboration with the team was smooth, and they were always available to address any concerns or questions we had. We were very satisfied with the outcome.
Dr. Laurie Bode II
9.2
- - Regulatory Strategy Consulting
- - 4 weeks July - August 2024
- - Biotech Startup
Reviewed:
Thorough and strategic regulatory strategy consulting.
The regulatory strategy consulting services were thorough and provided us with a clear pathway to regulatory approval. The team's deep understanding of the regulatory landscape was invaluable, and their strategic advice was spot on.
Audrey Runolfsdottir
8.8
- - Companion Diagnostics Development
- - 16 weeks January - May 2024
- - Pharmaceutical Company
Reviewed:
High-quality companion diagnostics development, delivered on time.
The development of companion diagnostics was of high quality, and the project was delivered on time. The team's technical expertise and understanding of the regulatory environment were key to the success of the project.
Janis Runolfsdottir
8.8
- - Biostatistical Design
- - 4 weeks May - June 2023
- - Research Institution
Reviewed:
Excellent biostatistical support, clear and actionable insights.
The biostatistical support provided was top-notch, offering clear and actionable insights that were critical to the success of our study. The team was responsive and worked closely with us to ensure the analysis met our specific needs.
